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Abstract.
The use of screening tools is an effective and practical approach within the
clinical diagnostic assessment of attention deficit hyperactivity disorder
(ADHD) in adults. Existing screening measures for adult ADHD have
focused on a younger population. Subsequently, the current study aimed
to evaluate the utility and general usability of an adapted four-item
screening tool for adult ADHD: a brief version of the Wender Utah
Rating Scale (WURS-brief), within a middle-aged population. The
sample consisted of 69 adults, aged between 30 and 63 (age M= 45,
SD=6.95), who had been referred to a specialist adult ADHD outpatients
clinic. Using factor analysis, the WURS-brief screening measure was
compared to existing ADHD diagnostic tools that were used as reference
measures within the analysis. The WURS-brief had respectable sensitivity
when compared with existing diagnostic tools. This study highlights the
importance of validating brief screening measures for middle-aged adults
with ADHD within clinical settings and offers suggestions for future
research.
Resumen.
El uso de herramientas de detección es un enfoque efectivo y práctico
dentro de la evaluación de diagnóstico clínico del trastorno por déficit
de atención con hiperactividad (TDAH) en adultos. Las medidas de
detección existentes para el TDAH en adultos se han centrado en una
población más joven. El presente estudio tuvo como objetivo evaluar la
utilidad y la usabilidad general de una herramienta de detección de cuatro
ítems adaptada para el TDAH en adultos: una versión breve de la Escala
de Calificación Wender Utah (WURS-brief), dentro de una población
de mediana edad. La muestra consistió en 69 adultos, con edades
comprendidas entre 30 y 63 años (edad M = 45, DE = 6.95), que habían
sido remitidos a una clínica especializada para pacientes externos con
TDAH en adultos. Mediante el análisis factorial, la medida de detección
breve de WURS se comparó con las herramientas de diagnóstico de
TDAH existentes que se utilizaron como medidas de referencia dentro del
análisis. El WURS-brief tenía una sensibilidad respetable en comparación
con las herramientas de diagnóstico existentes. Este estudio destaca
la importancia de validar breves medidas de detección para adultos de
mediana edad con TDAH dentro de entornos clínicos y ofrece sugerencias
para futuras investigaciones.
Keywords.
ADHD, Adult ADHD, Assessment, Validity, Screening, WURS, Wender
Utah Rating Scale.
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TDAH, TDAH en adultos, Evaluación, Validez, Screening, WURS,
Wender Utah Rating Scale.
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1. Introduction
Attention deficit hyperactivity disorder (ADHD) is a
common neuropsychiatric disorder characterised by a
pattern of inattention, hyperactivity, and impulsivity
(American Psychiatric Association, 2013). Despite ev-
idence of its prevalence and persistence into adulthood,
ADHD is still widely recognised as a childhood psychi-
atric disorder (Mannuzza & Klein, 2000). Longitudi-
nal studies have demonstrated the development of child-
hood ADHD into adult ADHD (Barkley et al., 2002; Bie-
derman et al., 2010; Kessler et al., 2005; Rasmussen &
Gillberg, 2000; Yoshimasu et al., 2018), as well as recent
research demonstrating the persistence of ADHD into
early adulthood and middle age (Barbaresi et al., 2013;
Caspi et al., 2005; Mannuzza et al., 2004; Mordre et al.,
2011). In spite of knowledge that ADHD persists into
adulthood, it is evident that adult ADHD has still only
recently become a focus for research. Although research
has been able to investigate the progression of ADHD
into early adulthood, information focusing on ADHD in
middle-aged adults is still scarce, despite a rapidly grow-
ing aging population. Service provision for adults with
ADHD is limited in many Western countries and close
to non-existent in other parts of the world. There is an
increasing demand on the health-service to support the
rise in middle-aged adults reporting a suspected history
of ADHD (Das et al., 2012; Manor et al., 2011). Di-
agnostic ascertainment for this group is therefore vital,
with importance in finding efficient ways of screening for
this disorder.
Due to ADHD diagnostic criteria being originally
developed for children (Applegate et al., 1997), mani-
festations of symptoms are more easily identifiable in
younger populations. It was not until the Fourth Edi-
tion of the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV;APA, 1994) that criteria for diag-
nosing adults with ADHD were included. The ADHD
diagnostic criteria in the Diagnostic and Statistical Man-
ual of Mental Disorders (Fourth Edition, Text Revision;
DSM-IV-TR; APA, 2000) was further altered in the lat-
est edition (Fifth Edition; DSM-V; APA, 2013) to recog-
nise the different symptom presentations of ADHD in
both childhood and adulthood. Despite this, diagnos-
ing ADHD in mid to late adulthood has potential addi-
tional barriers. This could be due to cognitive changes
in adults (i.e. executive functioning shortfalls, atten-
tion deficits, decline in working memory; Alderson et al.,
2013; Schweitzer et al., 2000), being misinterpreted as
executive function deficits found as a part of ADHD pre-
sentation. Subsequently, these errors could also cause
an increase in the number of false-positive ADHD diag-
noses received by middle-aged adults (Guldberg-Kjär &
Johansson, 2015). In addition to all of these challenges,
there is an increasing clinical demand for the assessment
of ADHD in adults (Murphy & Adler, 2004; Murray &
Weiss, 2001); therefore, highlighting the need to find re-
liable tools that accurately identify symptoms in adults.
Using screening tools alongside diagnostic measures
is cost-effective and could potentially save time for clini-
cians. In most clinical settings, the use of multiple com-
prehensive diagnostic interviews and assessments tends
to be a less practicable (Daigre et al., 2013; Daigre
Blanco et al., 2009). Screening tends to be used in the
initial stage of the diagnostic process, beginning an ef-
fective and timely journey towards diagnosis and sub-
sequent treatment (Corbisiero et al., 2017). The use
of a valid and reliable screening tool enables clinicians
to identify individuals with significant presentations of
ADHD symptoms, and administer comprehensive diag-
nostic assessments if the screening outcome is positive
(Young et al., 2016).
Due to the high prevalence of comorbidities in adult
ADHD (Faayad et al., 2007), it is vital to explore how
to adequately recognise ADHD in and amongst other
disorders. Screening tools have been recognised as an
important means of identification for the adult ADHD
population (Corbisiero et al., 2017).
The Wender Utah Rating Scale (WURS; Ward et
al., 1993) is an instrument that has been used widely in
the detection of ADHD-associated childhood symptoma-
tology amongst adults. The shortened version of the
WURS (Stein et al., 1995) has since been recognised
as a useful screening tool used to identify adults with
ADHD within non-ADHD populations (Dakwar et al.,
2012; Matas & Stanley, 1998; Ward et al., 1993). Using
exploratory factor analysis, Guldberg-Kjär and Johans-
son (2009) identified the four items with the highest
loading on each factor from the 25 items originally anal-
ysed by Ward et al. (1993) (Stein et al., 1995). These
four items were then used for attrition analysis, thus cre-
ating a Swedish short version of this instrument (which
shall be referred to in the currently study as the WURS-
brief). Due to these items effectively demonstrating the
highest predictors of persistent ADHD in adults, it is
likely that they are also effective in screening for adult
ADHD. Due to the WURS (Stein et al., 1995) being re-
garded as a time-consuming tool (Dakwar et al., 2012),
the WURS-brief would be an appropriate substitute.
The present aimed to investigate the psychometric
properties and clinical utility of the short questionnaire
(WURS-brief; Guldberg-Kjär & Johansson, 2009), in a
population of middle-aged adults referred to an ADHD
clinic.
2. Method
2.1 Participants
The sample consisted of 69 adults, aged between 30 and
63 (age M=45, SD=6.95). Participants were recruited
from a series of patients referred to adult ADHD outpa-
tient clinics across four locations.
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Participants recruited to the study were open to the
service between a data collection period of nine months
and desired sample size was set at N=60. All partici-
pants included in the study had to have completed their
psychiatric diagnostic assessment and received the out-
come before the data collection period ended. Study in-
clusion criteria was that participants were required to
be above the age of 30, and willing to complete the
WURS-brief questionnaire. As identified by their pa-
tient records, adults with moderate or severe learning
disabilities, organic brain injury or poor command of
English were excluded from the study. Seventy patients
were excluded (one patient had a learning disability and
lacked capacity to consent, 57 patients were not con-
tactable, and 12 patients refused participation), remain-
ing a total number of 69 participants in the study (Fig-
ure 1). There were 8 participants (11.6% of the total
sample) who were not diagnosed with ADHD and there-
fore were the healthy control group.
2.2 Instruments
2.2.1 Psychiatric diagnostic assessment.
The conclusion of a psychiatric diagnostic assessment
was determined through the reporting of an Interna-
tional Classification of Diseases (10th Revision; ICD-10;
World Health Organization, 2016) code on the partici-
pants’ ePJS record and psychiatric assessment report.
The ICD-10 is a medical classification system that lists
diagnostic criteria for conditions and diseases (WHO,
2016) and is the standard tool used in the United King-
dom in clinical psychiatric settings. Due to the diag-
noses included in the study being within the last ten
years, and there not being any change to the ADHD
ICD-10 coding system since then, the current study fol-
lowed the 2008 ICD-10 (World Health Organization, 2008)
list, and identified ADHD diagnoses to include the fol-
lowing diagnostic codes: Hyperkinetic disorders (F90)
and its sub-types: Disturbance of activity and attention
(F90.0), Hyperkinetic conduct disorder (F90.1), Hyper-
kinetic Other hyperkinetic disorders (F90.8), Hyperki-
netic disorder, unspecified (F90.9).
2.2.2 CAADID.
The CAADID is a widely used semi-structured inter-
view developed to examine ADHD symptoms categori-
cally and determine whether a diagnosis is present or
not (Ramos-Quiroga et al., 2012; Ramos-Quiroga et al.,
2019). The measure has been shown to be valid in its
ability to distinguish healthy controls from adults with
ADHD, along with having acceptable test-retest reliabil-
ity (Epstein & Kollins, 2006).
2.2.3 DIVA.
The DIVA (Kooij & Francken, 2010) is a structured in-
terview based on the DSM-IV criteria for ADHD (Kooij
et al., 2017; Pettersson et al., 2018). Research has pre-
viously explored the criterion validity of the DIVA di-
agnostic tool and suggested its high (100%) diagnostic
reliability and good concurrent validity with other self-
report scales such as the WURS (Pettersson et al., 2018;
Ramos-Quiroga et al., 2019). Sensitivity and specificity
values for overall diagnosis using the DIVA 2.0 have been
found to be high (90.0 and 72.9 respectively), according
to Pettersson et al. (2018). Although DIVA-5 is the
most recent version of the measure available, DIVA 2.0
was used within the current study due to it being the
measure used within routine clinical practice at the time
of data collection.
The diagnostic outcomes for each type of diagnos-
tic assessment were confirmed using the Trust’s patient
records database (ePJS).
2.3 Procedure
All patients were contacted through telephone. Addition-
ally, patients who were not contactable by telephone were
also emailed correspondence about the study if their email
addresswasrecordedonthepatientrecordsdatabase(elec-
tronicPatient Journey System; ePJS). Patientswere then
informed of the purpose for contact and were either read
the information sheet over the phone by the researcher,
or were presented with the document as an attachment, if
themodeofcontactwasemail. Participantswereprovided
with the aims and details of the study and were required
to provide consent-either verbally, or by replying to the
initial research email sent to them. Before and after the
study, participants were also informed of their right to
withdraw. Participants’ informed consent was recorded
on a data spread-sheet and ePJS.
The WURS-brief (adapted from Guldberg-Kjär &
Johansson, 2009) was used in this study as a screening
tool to estimate childhood ADHD symptomatology and
predict the risk of an ADHD diagnosis in adults. The
four items included in this study have been adapted from
the highest loading items on each factor of the WURS
(Guldberg-Kjär & Johansson, 2009):“Were you anxious
and worried as a child?”, “As a child, did you often have
outbursts or suddenly became very angry?”, “As a child,
did you ’first think and then act’, or were you following
your impulses?”, and “As a child, did you have difficul-
ties with numbers and/or mathematics?”. Participants
were asked to rate each of the four items on a five-point
Likert scale, in reference to childhood experiences: Not
at all or minimal (=0), To a certain extent (=1), Pretty
much (=2), Very much (=3), All the time (=4).
In real-world context, the process of ADHD diagno-
sis in adults tends to involve more than one diagnostic
tool. After screening, patients (and/or informants) are
invited to complete a diagnostic assessment (i.e. DIVA,
CAADID), which is then commonly followed by a psy-
chiatric diagnostic assessment with a psychiatrist. This
study therefore investigates the degree of agreement be-
tween the outcomes of the WURS-brief and a combina-
tion of tools used within the diagnostic process.
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Figure 1
Participant disposition during study
Table 1
WURS-brief and Clinicians diagnostic assessment cross-tabulation
WURS-brief CAADID DIVA Psychiatrist
ADHD
Positive
ADHD
Negative
ADHD
Positive
ADHD
Negative
ADHD
Positive
ADHD
Negative
ADHD Positive 10 1 25 12 54 7
ADHD Negative 0 0 4 2 7 1
Note. ADHD=Attention deficit hyperactivity disorder; ADHD positive indicates a score exceeding cut-off;
ADHD negative indicates a score below cut-off.
2.4 Data analyses
Outcomes for theWURS-brief, DIVA, CAADID and psy-
chiatricdiagnosticassessmentweredichotomised into“AD-
HD positive” and “ADHD negative”, based on whether
individuals surpassed the cut-off score for each measure.
The psychometric properties of the WURS-brief were
investigated using the three diagnostic tools as refer-
ences of high standard. Two additional variables were
generated to investigate the validity of WURS-brief with
respect to: The ’DIVA or CAADID’, and the ’DIVA
or CAADID, and the psychiatrist’s assessment’. These
variables were formed to reflect realistic use and ad-
ministration in clinical practice, as well as to test the
WURS-brie’s clinical utility. Tests of specificity (Maus-
ner & Bahn, 1977; Sparrow, 2010), sensitivity (Maus-
ner & Bahn, 1977; Sparrow, 2010), PPV (Parikh et al.,
2008), and NPV (Parikh et al., 2008) were computed for
the WURS-brief and arranged in a frequency table (see
Table 1) in relation to each of the diagnostic standards
individually and in combination.
These validity tests were supplemented by Cohen’s
Kappa (κ) test, used to determine the general agreement
between the referenced diagnostic tools (DIVA, CAA-
DID, psychiatric diagnostic assessment) and the WURS-
brief. All descriptive analysis and cross-tabulation pro-
cedures were conducted using IBM SPSS Version 26.
3. Results
Descriptive statistics were first computed to determine
the characteristics of the sample (Table 3). Frequency
distributions did not indicate any missing data for the
WURS-brief total score (Figure 2). Fifteen cases were
identified where there was no data for either the DIVA
or CAADID, as scores for these measures were not made
available and therefore were excluded from all analyses
pertaining to the DIVA and or CAADID.
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Table 2
Results for Sensitivity, Specificity, PPV, NPV, and Cohens Kappa (κ) for the WURS-brief
CAADID DIVA PA (ICD-10) DIVA orα
CAADID
DIVA or CAADID
andβ psychiatric
Sensitivity 1000.0 82.6 88.5 89.7 88.9
Specificity .0 14.3 12.5 13.3 11.1
PPV 90.9 67.6 88.5 72.9 66.7
NPV – 33.3 12.5 33.3 33.3
κ .00 .006 .010 .038 .00
Note. All values in the table represent percentages except κ. PPV=positive predictive value; NPV=negative
predictive value; CAADID=Conners’ Adult ADHD Diagnostic Interview for DSM-IV, dichotomised as ADHD
if six or more symptom criteria are present in both adulthood and childhood, and in either or both of the
domains Attention Deficit and Hyperactivity-Impulsivity, and as ADHD-negative if fewer than six symptom
criteria are present; DIVA=Diagnostic Interview for ADHD in Adults, dichotomised as ADHD if both five
or more symptom criteria in adulthood and six or more in childhood are present, and in either or both of
the domains Inattention and Hyperactivity-Impulsivity, and as non-ADHD if fewer than six or five symptom
criteria are present in the respective categories; Psychiatric=psychiatric diagnostic assessment, dichotomised
as ADHD if ICD-10 code of F90, F90.0, F90.1, F90.8 or F90.9 are given post full diagnostic interview with
clinician, and ADHD negative if another diagnostic code is given.
α ‘or’ indicates that the outcome on either assessment determined the diagnosis;
β ‘and’ indicates that the outcome of the combined means was required to determine the diagnosis.
Figure 2
Distribution of total brief Wender Utah Rating Scale (WURS-brief) score in the study sample (N=69)
Descriptive analyses were also conducted for the WU-
RS-brief total scores. The mean WURS-brief score in
the total sample was 8.38 (SD=3.71, Median=8, Range:
1–16). Sixty-one (88.4%) individuals in the sample (25
female, 36 male) scored above the computed cut-off score
of five or more (for total sample distribution of the
WURS-brief score, see to Figure 2). The mean score for
participants with a positive ADHD outcome from the
psychiatric assessment was 9 out of 16 (88.4%), with
54 (88.5%) of them scoring above 5 on the WURS-brief.
Amongst those with a positive ADHD outcome on the
CAADID, 10 (90.9%) participants scored 5 or more,
with a mean score of 10. For those who had an ADHD
outcome on the DIVA, 25 (86.2%) of the individuals
scored above the cut-off, with a mean score of 9.
In regards to the psychiatric diagnostic assessment,
the group with the outcome of ICD-10 F90.1 (Hyper-
kinetic conduct disorder) had the highest WURS-brief
score average (M=12.00, SD=4.00).
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The meanWURS-brief score for males was 8.31 (SD=
3.68) and 8.48 (SD=3.81) for females, with no significant
difference between the two groups (t67 = .38, p= .85).
3.1 Validity of the WURS-brief
The sensitivity, specificity, PPV, NPV, and Cohen’s Ka-
ppa (κ) were determined for the WURS-brief in respect
to the diagnostic references of high standard, as well as
the validity of the WURS-brief in agreement with the
diagnostic tools combined (Table 2).
3.2 Degreeofagreementwithcliniciansdiagnostic tools
The WURS-brief emerged with the highest level of sen-
sitivity (100%) and PPV (90.9%) when used with CAA-
DID. The sensitivity of the WURS-brief was very good
when used with the DIVA (82.6%) and psychiatrist’s
assessment (88.5%), despite poor levels of specificity in
relation to all three diagnostic instruments. The general
degree of agreement (κ) between the WURS-brief and
the diagnostic tools was poor for all outcomes (Table 2).
3.3 Degree of agreement with combined diagnostic tools
When computing the validity of the WURS-brief with
respect to the DIVA/CAADID, the sensitivity was very
good (89.7%). Similar levels of sensitivity (88.9%) were
also seen for theWURS-brief in relation to the DIVA/CA-
ADID combined with the psychiatrist’s assessment. The
value of κ (.038,.00) was poor for both combinations.
4. Discussion
The purpose of this study was to conduct analyses of val-
idation for the WURS-brief. All data was evaluated us-
ing descriptive analyses and cross-tabulation procedures
to determine the criterion validity of the WURS-brief.
As the ADHD population continues to age and the
clinical demand for adult ADHD assessment is increas-
ing, it is vital that the diagnostic process is made more
effective (Asherson et al., 2014). Previous research sug-
gests that individuals in mid-adulthood have more dif-
ficult experiences during the diagnostic process, due to
lack of reliable informants for childhood behaviours (Henry
et al., 1994). Further research supports this finding
and suggests that, even for individuals in early adult-
hood, both the individuals and their parents have lim-
ited ability to recall childhood presentations retrospec-
tively (Barkley et al., 2011; Miller et al., 2010). Despite
this, diagnostic procedures have yet to be streamlined,
and although there has been a review of existing screen-
ing tools available (Taylor et al., 2011), there is a limited
number of screening tools able to efficiently and effec-
tively identify the risk of adult ADHD diagnosis within
a clinical setting (Adult ADHD Self-Report Scale; Adler
et al., 2006). As previously mentioned, the WURS has
been criticised for its length and time-consumption as a
screening tool (Dakwar et al., 2012); therefore, identify-
ing the need for a brief and effective screening tool for
ADHD in adults. After Guldberg-Kjär and Johansson
(2009) identified the four items with the highest loading
on each factor of the WURS (Ward et al., 1993) and
used them as a tool for attrition analysis, these four
items (WURS-brief) were identified as the highest pre-
dictors of persistent ADHD in adults. For the current
study, the aim was to therefore use the WURS-brief as
a screening tool and validate its use as an identifier of
diagnostic risk in adults referred for ADHD assessment.
This study investigated the validity of the WURS-
brief as a screening instrument for adult ADHD, based
on clinical references of high clinical standard. Despite
previous studies (Dakwar et al., 2012) identifying the
validity of the 25-item WURS as a reliable screening
tool, the current study was the first to explore the utility
and the validity of a brief version of the WURS as a
screening tool.
With respect to the widely used clinical diagnostic
tools, the WURS-brief’s ability to identify individuals
with ADHD was ‘very good’ according to Sparrow’s
2010 evaluation of values. In relation to the CAADID,
the WURS-brief correctly identified 100% of the ADHD
cases. The WURS-brief was also able to correctly iden-
tify 82.6% of the ADHD diagnoses made with the DIVA,
and 88.5% of those identified through the psychiatric
assessment. When calculating the degree of agreement
between the WURS-brief and use of either the DIVA or
CAADID alongside a psychiatrist’s assessment, it was
able to correctly identify 88.9% of the ADHD cases.
In addition, the PPV for the WURS-brief in regards
to each of the clinical diagnostic tools (DIVA, CAA-
DID, psychiatric diagnostic assessment) ranged between
67.6% and 90.9%. Amongst those who had a positive
ADHD screening result, the probability of receiving a
diagnosis of ADHD with the DIVA was 67.6%. The
probability of a receiving a positive ADHD outcome on
the WURS-brief and also receiving a diagnosis with the
CAADID or psychiatric assessment were much higher,
with positive predictive values of 90.9% and 88.5% re-
spectively. These findings are mostly supportive of the
WURS-brief’s use as a valid screening tool for adults
referred for ADHD assessment. The current study’s
findings are supported by previous studies (Cuesta et
al., 2011; Dakwar et al., 2012; Wang et al., 2018) that
suggest that high sensitivity is the most important fac-
tor of a screening instrument, due to it aiming to de-
tect the maximum number of target cases and overlook
the minimum. Alternatively, specificity, negative predic-
tive values were poor for the WURS-brief. In relation
to the psychiatric diagnostic assessment and the DIVA,
only 14.3% of ADHD negative outcomes were accurately
predicted by the WURS-brief, with 0% being predicted
in relation to the outcome of the CAADID. Negative
predictive values were also low when the references of
diagnosis were combined (33.3%; DIVA/CAADID and
psychiatrist’s assessment). Kappa values for all compar-
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Table 3
Sample characteristics
Number Percentage
Sex
Male (Mage = 45; SDage = 7) 37 61.7
Female (Mage = 46; SDage = 7) 23 38.3
ICD-10 Diagnosis Code
F90 11 18.3
F90.0 34 56.7
F90.1 2 3.3
F90.8 3 5.0
F90.9 4 6.7
Other 6 10.0
Diagnostic Assessment
CAADID 11 23
DIVA 35 76.1
Psychiatric diagnostic assessment 60 100
Co-morbid disorders
Affective disorder 18 26
Anxiety disorder 15 21.7
Personality disorder 2 2.9
Other neurodevelopmental disorder 3 4.3
isons were low. These results indicate that among those
who had a negative ADHD screening result, the prob-
ability of also not receiving a diagnosis of ADHD with
the DIVA was low; this demonstrates poor ability to
discriminate, and therefore the WURS-brief’s struggle
to correctly identify participants without ADHD. Such
findings confirm the WURS-brief’s utility as a screening
tool for adult ADHD rather than a diagnostic instrument.
4.1 Clinical Implications
The current study presents both theoretical and clinical
implications, with this being the first study to exam-
ine the validity of the WURS-brief as a screening tool.
The study recognises the clinical relevance of validating
a screening tool, and therefore during investigation, re-
flected the clinical use of the WURS-brief by conducting
tests of validity with respect to the diagnostic tools it is
likely to be used alongside in application.
The current study also acknowledges the importance
of screening ADHD in adults, and therefore contributes
to the future development of a ‘gold standard’ screening
tool. With reports of high degrees of positive agree-
ment with multiple clinical diagnostic tools, it is clear
that the WURS-brief is on its way to becoming a valu-
able clinical instrument. Through the development of
the WURS-brief as a screening tool, it can be used to
quickly and efficiently screen large numbers of the at-risk
population of adults. This is especially true due to the
brief administration time of 1-2 minutes and its ability
to correctly predict a diagnosis of ADHD in adults.
4.2 Limitations
Findings of this study should be carefully interpreted
due to the limitations identified. Low specificity found
for the WURS-brief could be partially attributed to the
fact that all participants were referred to a specialist
adult ADHD clinic; this could have subsequently in-
creased the likelihood of ADHD symptoms being de-
tected and the likelihood of participants scoring above
cut-off on the screening tool, regardless of whether they
received a diagnosis of ADHD or not.
An overall specificity of 11.1% could also be attribut-
ed to the unreliability of retrospective self-report mea-
sures (Mannuzza et al., 2002; Murphy & Adler, 2004).
Due to participants needing to provide retrospective re-
sponses when completing the WURS-brief, it is likely
that there was an increase in the possibility of inaccu-
rate recall of childhood behaviours and response bias.
Similarly, responses may have been affected by a con-
firmation bias (Rabin & Schrag, 1999) or subjectivity,
both of which may have contributed to an overestima-
tion of behaviours associated with ADHD for those with-
out a clinical diagnosis, or an underestimation for those
with one. The sample could have also be more inclined
to endorse items they believed would support a diagno-
sis of ADHD (malingering; Ramsey, 2014), in order to
validate their referral to a specialist adult ADHD clinic.
Subsequently, the effect of bias on the reliability of the
WURS-brief as a self-report instrument must be con-
sidered. An alternative approach to reduce these biases
would be to have an informant (such as a parent, teacher
or sibling) confirm or provide an objective response to
the screening items.
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Due to high concurrent co-morbidity rates amongst
adults with ADHD, especially with affective and anxiety
disorders (Cumyn et al., 2009), the WURS-brief would
not be able to independently conclude whether present-
ing symptoms are correctly attributed to ADHD or are
better explained by a co-morbid disorder.
In addition to respondent bias, the outcome of the
study could also have been affected by instrument error.
For each item, participants were asked about behaviours
“as a child”. Despite many legal guidance referring to a
child as being under the age of 18 (i.e. The Family Law
Reform Act. UK Government Legislation, 1969), various
diagnostic tests make reference to specific age ranges (i.e.
between the ages of 5 and 12 is referenced in the DIVA
2.0; Kooij & Francken, 2010) when identifying presenta-
tion in childhood. As a result of this, there is a possi-
bility that respondents could have misinterpreted what
the questions referred to by using these words. Similarly,
the frequency expressions used in the Likert scales (i.e.
“To a certain extent”, “Pretty much”, “Very much”) left
much space for varying interpretations of each question
(Gliem & Gliem, 2003; Jamieson, 2004).
Although the researcher was blind to the diagnostic
outcomes at the time of data collection, limitations of
the study can also be extended to selection bias. Due
to the retrospective nature of the recruitment process,
many participants were unable to take part in the study,
because invalid contact details and lack of response to
correspondence requesting consent.
Due to the small sample size of 69 participants, all
sub-types of hyperkinetic disorder were collapsed into
the ADHD-positive group. This reduced the study’s
ability to detect differences between the ADHD sub-
types. The small control-group size also limits the study’s
ability to detect significant differences between the ADHD
positive and ADHD negative groups. With the scores of
the diagnostic assessment measures (CAADID, DIVA)
missing for some participants (n= 15), sample size also
limited the analyses of validity that investigated the
degree of agreement between the WURS-brief and the
CAADID and/or DIVA.
4.3 Future Considerations
While this study was able to offer insight into the extent
of the WURS-brief’s validity and utility as a screening
tool, it does not explain the overlap in symptomatol-
ogy between ADHD and other mental health disorders
(Mörstedt et al., 2015), as seen in previous studies with
the WURS (Stanton & Watson, 2016). This could likely
explain the low ability of the WURS-brief to distinguish
between ADHD cases and non-ADHD respondents. Ad-
ditionally, due to the WURS-brief focusing on retro-
spective recall about childhood presentations, future re-
search could explore an expansion of the items, with
information from informants. This could likely increase
the validity of the WURS-brief as a screening tool.
Due to the WURS-brief focusing on retrospective re-
call about childhood presentations, future research could
explore an expansion of the items, with information
from informants. This could likely increase the validity
of the WURS-brief as a screening tool. As previously
mentioned, the exploration of the WURS-brief’s valid-
ity was limited due to sample size and selection biases.
Future studies using the WURS-brief should focus on
obtaining more responses, so as to acquire a larger sam-
ple size.
4.4 Concluding Remarks
High sensitivity suggests that the WURS-brief could be
an effective screening tool for ADHD in middle-aged
adults within clinical practice. Findings suggest that
the instrument appears to be able to correctly predict a
diagnosis of ADHD, but is unable to distinguish between
other disorders and predict when ADHD is absent. De-
spite this, previous research has indicated that sensitiv-
ity takes priority over specificity in regards to the clinical
utility of a screening tool. Outcomes of this study were
able to validate the clinical utility of the WURS-brief
screening tool used within adult ADHD clinics. Further
expansion of the study, however, would better inform
the reliability and validation of the WURS-brief.
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The study protocol was reviewed and approved by the
ethics committees within South London & Maudsley
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